Response to British Journal of Sports & Exercise Medicine

The British Medical Journal Open Sports & Exercise Medicine recently published an article titled, “Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leukocyte-rich (type 1a) and leukocyte-poor (type 3b) platelet concentrates”.

 

Based on the outcomes of a study designed to evaluate the cellular components of platelet rich plasma (PRP), the authors claimed that leukocyte-rich PRP was superior to leukocyte-poor PRP when supporting the promotion of growth factor release and stimulation of tendon cell proliferation.

 

Leukocytes are white blood cells, a non-platelet component of platelet-rich plasma. There is current debate across the scientific and medical communities as to the role they play in platelet rich plasma treatments.

 

Dr. Marko Bodor, Ryan Dregalla, PhD and Yvette Uribe, BS read the article carefully and with great interest, given the current work they are doing in both clinical studies involving the delivery of PRP treatments and in laboratory research investigating PRP on a cellular level. They found inconsistencies in the authors’ preparation and use of the PRP within the study. The authors of the article did not actually use live PRP, but had frozen the platelets and used their extracts to stimulate growth factor release for the tendon cells.

 

Furthermore, the concentration of platelets in the leukocyte-rich preparation was 7-fold whereas in the leukocyte-poor it was 2-fold. As such, their conclusion regarding the superiority of the leukocyte-rich PRP for enhancing tendon cells growth was invalid. To be fair, the concentrations would need to be equal.

 

Dr. Bodor, Dregalla and Uribe have submitted a letter to the editor of the journal to point out their concerns, available here. With each step forward, we get closer to a future in which many of the degenerative conditions of today will not just be manageable, but curable and covered by insurance.

 

The Napa Medical Research Foundation is committed to the advancement of regenerative medicine. We believe it is essential for the scientific and medical community to work towards the development of less costly, less invasive treatments that utilize the body’s own healing agents to repair and regenerate. As researchers, medical professionals and community members, it is our duty to ensure accurate and timely information about these advances, to promote their safe and ethical use, and to prevent their misuse.

THE LATEST NEWS: January 2018

WELCOME TO THE BOARD Joann Serafini Ross is a native of Albany, New York and holds a BA in Communications from SUNY, New Paltz, New York. Her varied and diverse career has been filled with hard work and great experiences, all culminating in her current leadership and...

The Development of a New Technique

Innovations and breakthroughs can be the result of years’ worth of effort, multiple failures, and even happy accidents. For Dr. Marko Bodor, it was the driving need to ensure his patients were being diagnosed and treated in the most accurate, timely, effective and...

2017 Accomplishments

The Napa Medical Research Foundation continues to make major contributions in the field of regenerative medicine thanks to our innovative research team, dedicated staff and generous donors. Director of Research, Dr. Marko Bodor, combines his expertise in ultrasound and...

NMRF comments on Wall Street Journal article about stem cell research in U.S.

The recent Wall Street Journal article, “Stem Cells for Knee Injuries? U.S. Doctors Investigate”, presents an important case for the critical research being performed across the country to prove the efficacy of regenerative biologic treatments, including stem cells...

Investing in the Future

 Reduce Pain. Increase Mobility + Function. Improve Quality of Life. All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family...

Napa Valley Marketplace magazine

Dr. Marko Bodor through the Bodor Clinic and the Napa Medical Research Foundation is pioneering new techniques in regenerative medicine to keep patients free of pain and off the operating table. Using the patient’s own red blood cell platelets and stem cells, Dr....

Welcome to the Board, Joann Serafini Ross

Joann Serafini Ross is a native of Albany, New York and holds a BA in Communications from SUNY, New Paltz, New York. Her varied and diverse career has been filled with hard work and great experiences, all culminating in her current leadership and mentoring roles....

Surgery During Harvest

Michael Wolf, owner of Michael Wolf Vineyard Services and long-time Napa Valley grape producer, suffered for years from Carpal Tunnel Syndrome in both wrists.   Like the 12 million other Americans with this condition, Mike was experiencing numbness, tingling, and...

Welcome Dr. Harry Genant

Harry K. Genant, MD, is Professor Emeritus of the University of California San Francisco and currently serves as a Senior Consultant, and past Member of the Board of Directors and Chairman Emeritus of Bioclinica-Synarc, Inc., a global contract research organization he...

Response to British Journal of Sport & Exercise Medicine

The British Medical Journal Open Sports & Exercise Medicine recently published an article titled, “Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leukocyte-rich (type 1a) and leukocyte-poor (type...

Categories

 Reduce Pain. Increase Mobility + Function. Improve Quality of Life.

All the research conducted through the Napa Medical Research Foundation, a 501(c)(3) nonprofit organization, is fully funded through generous donations received from individuals and family foundations.

Pin It on Pinterest

Share This